SCHEMBL7984459

SCHEMBL7984459

Oc1nc(-c2ccc(Cl)cc2)nc2ncn(Cc3ccccc3)c12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR1H2 P55055 2/20 0.43
▸ NR1H3 Q13133 1/20 0.43
▸ SMN1; SMN2 Q16637 5/20 0.42
▸ ALDH1A1 P00352 3/20 0.42
▸ CYP11B1 P15538 3/20 0.41
▸ CYP11B2 P19099 3/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ HPGD P15428 1/20 0.40
▸ ADORA2A P29274 2/20 0.40
▸ KMT2A Q03164 1/20 0.39
▸ ADORA3 P0DMS8 1/20 0.39
▸ ADORA1 P30542 1/20 0.39
▸ CNR1 P21554 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ HPGDS O60760 1/20 0.38
▸ PARN O95453 1/20 0.38
▸ CNOT7 Q9UIV1 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ TNF P01375 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7991405 0.95 CYP11B1 (0.45) NR1H2NR1H3SMN1; SMN2ALDH1A1CYP11B1
SCHEMBL7975267 0.92 SMN1; SMN2 (0.46) NR1H3SMN1; SMN2ALDH1A1CYP11B1CYP11B2
SCHEMBL7988558 0.91 SMN1; SMN2 (0.43) SMN1; SMN2ALDH1A1CYP11B1CYP11B2HPGD
SCHEMBL7975133 0.90 ADORA2A (0.50) SMN1; SMN2ALDH1A1CYP11B1CYP11B2HPGD
SCHEMBL7974507 0.89 MET (0.46) SMN1; SMN2ALDH1A1CYP11B1CYP11B2HPGD
Hydrochloric Acid SCHEMBL7985515 0.89 ADORA2A (0.49) SMN1; SMN2ALDH1A1CYP11B1CYP11B2HPGD
SCHEMBL7988668 0.88 SMN1; SMN2 (0.44) SMN1; SMN2ALDH1A1CYP11B1CYP11B2MAPK1
SCHEMBL7974441 0.88 GRK2 (0.43) SMN1; SMN2ALDH1A1CYP11B1CYP11B2HPGD
SCHEMBL7974012 0.87 ALDH1A1 (0.41) SMN1; SMN2ALDH1A1CYP11B1CYP11B2HTT
SCHEMBL7985225 0.86 GAA (0.48) SMN1; SMN2ALDH1A1CYP11B1CYP11B2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 — — US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 — — EP disclosed
Send feedback